Alantra advised Sangamo Therapeutics on the public tender offer followed by a squeeze-out on TxCell
SECTORHealthcare
ServiceM&A; Equity Capital Markets
Related Transactions
-
Apr 2025Sell-side advisoryApr 2025SECTOR HealthcareService M&A
-
Apr 2025Accelerated BookbuildingValue c. €42.4mnApr 2025SECTOR HealthcareService Equity Capital MarketsValue c. €42.4mn
-
Mar 2025Buy-side advisoryMar 2025SECTOR HealthcareService M&A
-
Dec 2024Corporate BrokerDec 2024SECTOR HealthcareService Corporate Broker; Equity Capital Markets